Cargando…
Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance
Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infe...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828092/ https://www.ncbi.nlm.nih.gov/pubmed/34591738 http://dx.doi.org/10.1080/21645515.2021.1969853 |
_version_ | 1784647783089700864 |
---|---|
author | Marchetti, Federico Prato, Rosa Viale, Pierluigi |
author_facet | Marchetti, Federico Prato, Rosa Viale, Pierluigi |
author_sort | Marchetti, Federico |
collection | PubMed |
description | Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infected cases in need of antibiotics. We conducted a survey among Italian vaccine experts to record their opinion regarding the role of vaccinations against antibiotic resistance (ABR). Among 80 invited experts, 51 answered all questions. Most respondents were experts in hygiene and preventive medicine (56.9%) and aged >50 years (72.6%). ABR was a priority concern in the daily professional activity of 82.4% of respondents. Overall, 47.1% of respondents believed that all vaccinations included in the vaccination calendar played a role against ABR: 92.2% for pertussis vaccination followed by 88.2%, 74.5%, and 70.6% for meningococcus, measles, and varicella vaccinations, respectively. Almost all respondents agreed that the role of vaccinations against ABR should be clearly expressed in the national vaccination guidelines (96.1%) and Scientific Societies should take an explicit position on the issue (92.2%). These results show that Italian experts have recognized the vaccinations’ potential role in limiting ABR and guidelines from the appropriate scientific and governmental authorities are needed. |
format | Online Article Text |
id | pubmed-8828092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88280922022-02-10 Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance Marchetti, Federico Prato, Rosa Viale, Pierluigi Hum Vaccin Immunother Short Report Antimicrobial resistance (AMR) is a major public health problem threatening to reverse the progress made against infectious diseases. The rapid increase of AMR exposes Italian hospitals at increased risk of untreatable infections. Vaccinations can potentially limit AMR by reducing the number of infected cases in need of antibiotics. We conducted a survey among Italian vaccine experts to record their opinion regarding the role of vaccinations against antibiotic resistance (ABR). Among 80 invited experts, 51 answered all questions. Most respondents were experts in hygiene and preventive medicine (56.9%) and aged >50 years (72.6%). ABR was a priority concern in the daily professional activity of 82.4% of respondents. Overall, 47.1% of respondents believed that all vaccinations included in the vaccination calendar played a role against ABR: 92.2% for pertussis vaccination followed by 88.2%, 74.5%, and 70.6% for meningococcus, measles, and varicella vaccinations, respectively. Almost all respondents agreed that the role of vaccinations against ABR should be clearly expressed in the national vaccination guidelines (96.1%) and Scientific Societies should take an explicit position on the issue (92.2%). These results show that Italian experts have recognized the vaccinations’ potential role in limiting ABR and guidelines from the appropriate scientific and governmental authorities are needed. Taylor & Francis 2021-09-30 /pmc/articles/PMC8828092/ /pubmed/34591738 http://dx.doi.org/10.1080/21645515.2021.1969853 Text en © 2021 GlaxoSmithKline Biologicals SA. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Report Marchetti, Federico Prato, Rosa Viale, Pierluigi Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance |
title | Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance |
title_full | Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance |
title_fullStr | Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance |
title_full_unstemmed | Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance |
title_short | Survey among Italian experts on existing vaccines’ role in limiting antibiotic resistance |
title_sort | survey among italian experts on existing vaccines’ role in limiting antibiotic resistance |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828092/ https://www.ncbi.nlm.nih.gov/pubmed/34591738 http://dx.doi.org/10.1080/21645515.2021.1969853 |
work_keys_str_mv | AT marchettifederico surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance AT pratorosa surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance AT vialepierluigi surveyamongitalianexpertsonexistingvaccinesroleinlimitingantibioticresistance |